請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/87226
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 潘令妍 | zh_TW |
dc.contributor.advisor | Ling-Yen Pan | en |
dc.contributor.author | 林妏珊 | zh_TW |
dc.contributor.author | Wen-Shan Lin | en |
dc.date.accessioned | 2023-05-18T16:28:58Z | - |
dc.date.available | 2023-11-10 | - |
dc.date.copyright | 2023-05-11 | - |
dc.date.issued | 2023 | - |
dc.date.submitted | 2023-02-17 | - |
dc.identifier.citation | 英文文獻
1.Allied Market Research. (2022, March). Cataract Surgery Devices Market. https://www.alliedmarketresearch.com/cataract-surgery-device-market 2.Alcon (2021, March 24). 2021 Capital Markets Day. https://investor.alcon.com/news-and-events/events-and-presentations/event-details/2021/2021-Capital-Markets-Day/default.aspx 3.Barney, J (1991). Firm resources and sustained competitive advantage, Journal of Management, 17(1), 99-121. 4.Boyer, P., Morshed, B. I., & Mussivand, T. (2015). Medical Device Market in China. Artificial Organs, 39(6), 520-525. 5.Burton, M. J., Ramke, J., Marques, A. P., Bourne, R. R., Congdon, N., Jones, I., ... & Faal, H. B. (2021). The Lancet global health Commission on global eye health: Vision beyond 2020. The Lancet Global Health, 9(4), e489-e551. 6.Buzzell, R D; Gale, B T & Sultan, R (1975). Market share: A key to profitability. Harvard Business Review, 53(1), 97-106. 7.Carpenter, G. S., & Nakamoto, K. (1990). Competitive strategies for late entry into a market with a dominant brand. Management Science, 36(10), 1268-1278. 8.GBD 2019 Blindness and Vision Impairment Collaborators; Vision Loss Expert Group of the Global Burden of Disease Study. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. Lancet Glob Health. 9(2), e144-e160. https://www.doi.org/10.1016/S2214-109X(20)30489-7. 9.Guasch, J. L., & Weiss, A. (1980). Adverse selection by markets and the advantage of being late. The Quarterly Journal of Economics, 94(3), 453-466. 10.Grennan, M. (2014). Bargaining ability and competitive advantage: Empirical evidence from medical devices. Management Science, 60(12), 3011-3025. 11.Hafeez, K., Zhang, Y., & Malak, N. (2002). Core competence for sustainable competitive advantage: A structured methodology for identifying core competence. IEEE Transactions on Engineering Management, 49(1), 28-35. 12.Javidan, M. (1998). Core competence: What does it mean in practice?. Long Range Planning, 31(1), 60-71. 13.Joung, Y. H. (2013). Development of implantable medical devices: from an engineering perspective. International Neurourology Journal, 17(3), 98-106. 14.Kalyanaram, G., Robinson, W. T., & Urban, G. L. (1995). Order of market entry: Established empirical generalizations, emerging empirical generalizations, and future research. Marketing Science, 14(3), G212-G221. 15.Kerin, R. A., Varadarajan, P. R., & Peterson, R. A. (1992). First-mover advantage: A synthesis, conceptual framework, and research propositions. Journal of Marketing, 56(4), 33-52. 16.Kim, D., Ryu, G. H., Shin, K., & Lee, K. S. (2021). What are the success factors for a partnership with global medical device companies? Evidence from Korea. Journal of Open Innovation: Technology, Market, and Complexity, 7(4), 237. 17.Kirk Smick, O. D., & Villette, T. (2013). Blue light hazard. REPORT OF A ROUNDTABLE: New York City. 18.Koszulinski, A., Sandoval, J., Vendeuvre, T., Zeghloul, S., & Laribi, M. A. (2022). Comanipulation robotic platform for spine surgery with exteroceptive visual coupling: development and experimentation. Journal of Medical Devices, 16(4), 041002. 19.Kwitko, M. L., & Kelman, C. D. (Eds.). (1998). The History of Modern Cataract Surgery. Kugler Publications. 20.Lambkin, M. (1988). Order of entry and performance in new markets. Strategic Management Journal, 9(S1), 127-140. 21.Lambkin, M., & Day, G. S. (1989). Evolutionary processes in competitive markets: beyond the product life cycle. Journal of Marketing, 53(3), 4-20. 22.Lee, T. W. (1999). Using Qualitative Methods in Organizational Research. Sage. 23.Lieberman, M. B., & Montgomery, D. B. (1988). First‐mover advantages. Strategic Management Journal, 9(S1), 41-58. 24.Lind, K. D. (2017). Understanding the market for implantable medical devices. Insight, 1, 1-15. 25.Long, Carl & Vickers-Koch Mary. (1995). Using core capabilities to great competitive advantage. Organizational Dynamics. 24(1), 6-21. 26.Mansfield, E., Schwartz, M., & Wagner, S. (1981). Imitation costs and patents: An empirical study. The Economic Journal, 91(364), 907-918. 27.Mitsukuni, N. (2017). First-mover advantage through distribution: A decomposition approach, Marketing Science, 36(4), 590-609. 28.Pane, J., Francisca, R. D., Verhamme, K. M., Orozco, M., Viroux, H., Rebollo, I., & Sturkenboom, M. C. (2019). EU post market surveillance plans for medical devices. Pharmacoepidemiology and Drug Safety, 28(9), 1155-1165. 29.Panta, G., Richardson, A. K., & Shaw, I. C. (2019). Effectiveness of autoclaving in sterilizing reusable medical devices in healthcare facilities. The Journal of Infection in Developing Countries, 13(10), 858-864. 30.Pesapane, F., Volonté, C., Codari, M., & Sardanelli, F. (2018). Artificial intelligence as a medical device in radiology: Ethical and regulatory issues in Europe and the United States. Insights into Imaging, 9, 745-753. 31.Piuzzi, N. S., Ng, M., Song, S., Bigach, S., Khlopas, A., Salas-Vega, S., & Mont, M. A. (2019). Consolidation and maturation of the orthopaedic medical device market between 1999 and 2015. European Journal of Orthopaedic Surgery & Traumatology, 29(4), 759-766. 32.Porter, M. E. (1980). Competitive Strategy: Technical for Analysing Industries and Competitors. The Free Press, New York. 33.Prahalad, C. K., & Hamel, G. (1994). Strategy as a field of study: Why search for a new paradigm?. Strategic Management Journal, 15(S2), 5-16. 34.Rashid, Y., Rashid, A., Warraich, M. A., Sabir, S. S., & Waseem, A. (2019). Case study method: A step-by-step guide for business researchers. International Journal of Qualitative Methods, 18, 1-13. 35.Rein, D. B., Zhang, P., Wirth, K. E., Lee, P. P., Hoerger, T. J., McCall, N., ... & Saaddine, J. (2006). The economic burden of major adult visual disorders in the United States. Archives of Ophthalmology, 124(12), 1754-1760. 36.Robinson, W. T. and Fornell, C. (1985). Sources of market pioneer advantages in consumer goods industries, Journal of Marketing Research, 22(3), 305-317. 37.Rumelt, R. P. (1984). Towards a strategic theory of the firm. Competitive Strategic Management, 26(3), 556-570. 38.Sabatiera, M. and Cholletb, B. (2017). Is there a first mover advantage in science? Pioneering behavior and scientific production in nanotechnology, Research Policy, 46(2), 522-533. 39.Schmalensee, R.(1982). Product differentiation advantages of pioneering brands. The American Economic Review, 72(3), 349-365. 40.Shih, Y. H., Chang, H. Y., Lu, M. I., & Hurng, B. S. (2014). Time trend of prevalence of self-reported cataract and its association with prolonged sitting in Taiwan from 2001 and 2013. BMC Ophthalmology, 14, 1-9. 41.Spender, J C (1993). Competitive advantage from tacit knowledge? Unpacking the concept and its strategic implications, Academy of Management Best Papers Proceedings, 1993(1), 37-41. 42.Srivastava, S. C. (2005). Managing core competence of the organization. Vikalpa, 30(4), 49-64. 43.Steinmetz, J. D., Bourne, R. R., Briant, P. S., Flaxman, S. R., Taylor, H. R., Jonas, J. B., ... & Morse, A. R. F. (2021). Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. The Lancet Global Health, 9(2), e144-e160. 44.Teece, D. J., G. Pisano, and A. Shuen (1997). Dynamic capabilities and strategic management. Strategic Management Journal, 18(7), 509-533. 45.Urban, G. L., Carter, T., Gaskin, S., & Mucha, Z. (1986). Market share rewards to pioneering brands: An empirical analysis and strategic implications. Management Science, 32(6), 645-659. 46.Varma, S. D., Kovtun, S., & Hegde, K. R. (2011). Role of ultraviolet irradiation and oxidative stress in cataract formation—medical prevention by nutritional antioxidants and metabolic agonists. Eye & Contact Lens, 37(4), 233-245. 47.Hassija, V., Chamola, V., Bajpai, B. C., & Zeadally, S. (2021). Security issues in implantable medical devices: Fact or fiction?. Sustainable Cities and Society, 66, 102552. 48.Von Weizsacker, C. C. (1980). A welfare analysis of barriers to entry. The Bell Journal of Economics, 399-420. 49.Wernerfelt, B (1984). “A Resource-based View of the Firm,” Strategic Management Journal, 5(2), 171-180. 50.World Health Organization. (2022, October 13). Blindness and vision impairment. https://www.who.int/news-room/fact-sheets/detail/blindness-and-visual-impairment 51.Zaldivar, D., Lo'ai, A. T., & Muheidat, F. (2020). Investigating the security threats on networked medical devices. In 2020 10th Annual Computing and Communication Workshop and Conference (CCWC), 0488-0493. 52.Zhang, X., Ely, G., Shin, B., and Anthony, B. W. (2022). Multimanipulator robotic system for ultrasound tomography: Design, calibration, and image results. ASME. J. Med. Devices. 16(4), 041013. 中文文獻 1.C. Frankfort-Nachmias & David Nachimias(2003)。最新社會科學研究方法(潘明宏、陳志瑋譯)。台北,韋伯文化。(原著出版於1996年) 2.David W. Stewart、Michael A. Kamins(2000)。次級資料研究法(董旭英、黃儀娟譯)。弘智。(原著出版於1984年) 3.汪開勛、蕭育仁、林彥光、丁台怡。台灣門診及住院眼睛手術處置之流行病學:2012-2019年。Journal of Data Analysis,16(3)。65-79。 4.李佳靜、莊慧瑛、劉耿彰(2007)。醫療器材:如何促進病人安全。慈濟醫學雜誌,19(1_s),49-53。 5.李益志、黃承好(2018)。準分子雷射與飛秒雷射在眼科手術上的應用。機械工業雜誌,419,26-33。 6.李爾芳(2022)。醫用超音波影像市場與疫情下產品發展趨勢。工研院產科國際所。 7.李爾芳、李旻軒、吳劭易、林怡欣、徐勤禎、張慈映、劉家豪。2022醫療器材產業年鑑。工研院產科國際所。 8.吳俊璋(2012)。醫療器材電性安全法規之整編。﹝碩士論文。中原大學﹞臺灣博碩士論文知識加值系統。https://hdl.handle.net/11296/98h7b9 9.林坤輝(2013)。新創骨科醫療器材公司的競爭策略分析與建議。﹝碩士論文。國立臺灣大學﹞臺灣博碩士論文知識加值系統。 https://hdl.handle.net/11296/6rn55t 10.易光燿(2017)。高階眼科醫材公司之競爭策略分析─以A公司為例。﹝碩士論文。國立中央大學﹞臺灣博碩士論文知識加值系統。 https://hdl.handle.net/11296/xmkrv5 11.姜秀子、李聰明、陳瀅淳、盧彥伶、劉昌邦、施智源、薛博仁、李秋香(2022)。單次使用醫療器材再處理之感染管制。感染控制雜誌,30(2),120-128。 12.財政部關務署(2023)。海關進出口統計。https://portal.sw.nat.gov.tw/APGA/GA30 13.彭玉樹、梁奕忠、于卓民、梁晉嘉(2010)。台灣管理學門質性研究之回顧與展望。中山管理評論,18(1),11 - 39。 14.黃俊英(1994)。企業研究方法。台北,東華。 15.夏昀、何子昌(2021)。白內障治療之醫病共享決策。台灣醫學,25(2),226-230。 16.陳惠玉(2016)。台灣眼科高階醫療儀器之經營策略─C公司為例。﹝碩士論文。國立中央大學﹞臺灣博碩士論文知識加值系統。 https://hdl.handle.net/11296/756s9b 17.張淑雯(2009年9月)。年老眼花,白內障的預防與治療。亞東院訊第118期。https://www.femh.org.tw/magazine/viewmag?ID=1903 18.楊榮森(2019)。積層製造(3D列印)醫療器材在骨科的新進展-緒言。台灣醫學,23(1),38-40。 19.榮泰生(2011)。企業研究方法,台北:五南。 20.潘淑滿(2022)。質性研究理論與應用。台北:心理。 21.衛生福利部國民健康署(2022年3月29日)。民國一百零八年中老年身心社會生活狀況長期追蹤調查成果報告。衛生福利部國民健康署。https://www.hpa.gov.tw/Pages/ashx/File.ashx?FilePath=~/File/Attach/1282/File_18237.pdf 22.衛生福利部(2022年9月8日)。109年度全民健康保險醫療統計年報。衛生福利部統計處)。https://dep.mohw.gov.tw/DOS/lp-5103-113-xCat-y109.html 23.衛生福利部中央健康保險署(2022年10月20日)。診療項目醫令申報量。https://www.nhi.gov.tw/Content_List.aspx?n=8858783BC0803C2F&topn=23C660CAACAA159D 24.衛生福利部中央健康保險署(2023年2月7日)。醫材比價網。https://www.nhi.gov.tw/QueryN_New/SpecialMaterial/SpecialMaterialDiff/EasyFilter 25.賴昭弟(2014)。台灣地區眼科白內障手術趨勢分析及其影響醫療成效之研究。﹝碩士論文。高雄醫學大學﹞。Airiti Library華藝線上圖書館。https://www.airitilibrary.com/Publication/alDetailedMesh1?DocID=U0011-1107201415254100 | - |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/87226 | - |
dc.description.abstract | 全球人口朝向高齡化結構演進,各種慢性病之罹病率增加,其中以白內障罹病率佔第二位。再加上3C產品過度使用,導致近十年來,白內障就診民眾甚至有愈來愈年輕化之趨勢,導致相關醫療的市場需求逐年增加,白內障手術醫材產業持續穩定成長。然而,回顧醫療器材產業及市場相關研究中,有關白內障手術醫材產業研究卻相對稀少,引發研究者希冀多加了解的契機。此外,在與市場領導者市佔率相差相當懸殊的情況下,B公司所採取的後進者策略,讓其在市場中仍然佔有一席之地,更是本研究希望進一步分析此個案之緣由。
本研究之目的大致有三:(一)了解白內障手術醫材產業現有狀況及未來的市場趨勢發展;(二)運用理論架構來分析B公司於產業中的發展策略,並希望藉此探討B公司的產品定位、經營策略及其核心能耐;(三)對於白內障手術儀器之市場經營策略提出可行建議。研究中所採取的是質性研究方法中的次級資料法、個案研究法與深度訪談法,並以B公司為個案研究對象,蒐集該公司及相關產業資訊的次級資料,運用個案研究法進行探究,再加上深度訪談個案相關人員,以獲得更進一步的資訊與洞察。 本研究透過後進者策略與核心能耐的理論視角來進行分析,試圖釐清B公司在市場中的努力及其現存的相對優勢為何。而主要的研究結果顯示:白內障手術儀器市場為寡佔市場,且競爭廠商皆為基礎資源相對雄厚的跨國企業,擁有獨特的核心技術與行銷能力。此外,人力資源在此產業的經營策略確實占有重要角色,後進者能藉由搭便車效應,獲取先進者的人力,進而複製先進者的策略,搶佔剩餘市場。但能否留任有經驗、能對組織有所貢獻的人才、以及組織文化及管理者領導方式,未來將可能是重要的關鍵因素,亦是先進者也是後進者需要鞏固及強化之處。 | zh_TW |
dc.description.abstract | The world’s population is aging and the incidence of various chronic diseases is increasing, with cataract being the second highest in Taiwan. Nowadays, people spend a lot of time using 3C products, and the rate of cataract visits in the younger group has been steadily increasing over the past decade. An increase in the prevalence of cataract is driving the growth of the cataract surgery devices market. However, a review of the medical device industry and market research shows that there is relatively little research on the cataract surgery devices market, which has led researchers to ask for more insights. In addition, the fact that Company B has adopted a latecomer strategy, which has allowed it to gain a foothold in the market despite a significant difference in market share from the market leader, is the reason why this study wishes to analyze the case further.
The objectives of this study are broadly threefold: (1) to understand the current situation and future market trends in the cataract surgery industry; (2) to apply a theoretical framework to analyze Company B’s development strategy in the industry, with a view to exploring Company B’s product positioning, business strategy, and core competencies; and (3) to make feasible recommendations on the market operation strategy for cataract surgery devices. The current study employed qualitative research using secondary data, a case study, and in-depth interviews. Company B was used as the target for this study to collect secondary data on the company and related industry information, and the case study method was used to explore the case along with in-depth interviews to gain further information and insights. The analysis was conducted through the theoretical lens of latecomer strategy and core competencies in an attempt to clarify Company B’s efforts in the market and its existing relative strengths. Key findings revealed that the cataract surgical devices market is oligopolistic, with competitors being multinational companies with relatively strong infrastructural resources, unique core technologies and marketing capabilities. In addition, human resources play an important role in the industry’s business strategy, as latecomers are able to capture the remaining market by replicating the first movers’ strategies through the free-rider effect of acquiring their manpower. However, the ability to retain experienced people who can contribute to the organization, as well as the culture and leadership style of the organization, are likely to be key factors in the future and are areas that both first and second movers need to consolidate and strengthen. | en |
dc.description.provenance | Submitted by admin ntu (admin@lib.ntu.edu.tw) on 2023-05-18T16:28:57Z No. of bitstreams: 0 | en |
dc.description.provenance | Made available in DSpace on 2023-05-18T16:28:58Z (GMT). No. of bitstreams: 0 | en |
dc.description.tableofcontents | 口試委員會審定書i
誌謝ii 中文摘要iii ABSTRACT iv 目錄vi 圖目錄viii 表目錄ix 第一章 緒論1 第一節 研究背景與動機1 第二節 研究目的3 第三節 研究流程3 第二章 文獻回顧5 第一節 醫療器材產業及市場相關研究5 第二節 白內障手術醫材產業概況7 第三節 先進者與後進者策略17 第四節 核心能耐25 第三章 研究方法32 第一節 質性研究:次級資料分析、個案研究法與深度訪談法32 第二節 研究架構與範疇37 第四章 研究結果38 第一節 B公司白內障手術儀器部門之個案介紹38 第二節 B公司白內障手術儀器部門的後進者策略與核心能耐分析48 第五章 結論與討論61 第一節 主要研究發現與討論61 第二節 研究貢獻與實務意涵64 第三節 研究限制與未來研究方向66 參考文獻68 英文文獻68 中文文獻73 | - |
dc.language.iso | zh_TW | - |
dc.title | 眼科手術醫療器材市場之後進者策略研析— 以B公司白內障手術儀器部門個案為例 | zh_TW |
dc.title | The Strategies of Latecomers in the Ophthalmology Surgical Devices Market—The Cases of the Cataract Surgical Departments of the B Company | en |
dc.type | Thesis | - |
dc.date.schoolyear | 111-1 | - |
dc.description.degree | 碩士 | - |
dc.contributor.oralexamcommittee | 胡凱焜;余峻瑜 | zh_TW |
dc.contributor.oralexamcommittee | Kae-Kuen Hu;Jiun-Yu Yu | en |
dc.subject.keyword | 眼科手術醫療器材,白內障手術,後進者策略,核心能耐,質性研究, | zh_TW |
dc.subject.keyword | Ophthalmic surgical devices,Cataract surgery,Late-mover strategy,Core competencies,Qualitative research, | en |
dc.relation.page | 75 | - |
dc.identifier.doi | 10.6342/NTU202300584 | - |
dc.rights.note | 未授權 | - |
dc.date.accepted | 2023-02-18 | - |
dc.contributor.author-college | 進修推廣學院 | - |
dc.contributor.author-dept | 生物科技管理碩士在職學位學程 | - |
顯示於系所單位: | 生物科技管理碩士在職學位學程 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-111-1.pdf 目前未授權公開取用 | 1.78 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。